Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire L Watkins

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|February 20, 2007
Tilt and reading speedAlison Y Firth, Jason Machin, Claire L Watkins
The Patient|January 26, 2012
A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung CancerAlistair E Ring, Kerry A Cheong, Claire L Watkins, et al.
British Journal of Clinical Pharmacology|November 4, 2004
Effect of oral linezolid on the pressor response to intravenous tyramineMireille V Cantarini, Catherine J Painter, Elaine M Gilmore, et al.
Breast Cancer Research : BCR|September 26, 2013
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancerRebecca A Dent, Geoffrey J Lindeman, Mark Clemons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trialJean-Yves Douillard, Frances A Shepherd, Vera Hirsh, et al.
The New England Journal of Medicine|August 21, 2009
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaTony S Mok, Yi-Long Wu, Sumitra Thongprasert, et al.
Lancet (London, England)|November 26, 2008
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trialEdward S Kim, Vera Hirsh, Tony Mok, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|February 20, 2007
Tilt and reading speedAlison Y Firth, Jason Machin, Claire L Watkins
The Patient|January 26, 2012
A Randomized Study of Electronic Diary versus Paper and Pencil Collection of Patient-Reported Outcomes in Patients with Non-Small Cell Lung CancerAlistair E Ring, Kerry A Cheong, Claire L Watkins, et al.
British Journal of Clinical Pharmacology|November 4, 2004
Effect of oral linezolid on the pressor response to intravenous tyramineMireille V Cantarini, Catherine J Painter, Elaine M Gilmore, et al.
Breast Cancer Research : BCR|September 26, 2013
Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancerRebecca A Dent, Geoffrey J Lindeman, Mark Clemons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trialJean-Yves Douillard, Frances A Shepherd, Vera Hirsh, et al.
The New England Journal of Medicine|August 21, 2009
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinomaTony S Mok, Yi-Long Wu, Sumitra Thongprasert, et al.
Lancet (London, England)|November 26, 2008
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trialEdward S Kim, Vera Hirsh, Tony Mok, et al.
Pageof 1